Cancer Vaccines Market by Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvent Cancer Vaccines, Viral Vector and DNA Cancer Vaccines), Type (Preventive Vaccine, Therapeutic Vaccine), Indication (Prostate Can

"Market Definition
The Global Cancer Vaccines Market market size was valued at USD 5.68 billion in 2019 and is estimated to garner USD 24.32 billion by 2030, expanding at a CAGR of 14.0% during the forecast period, from 2020-2030
Cancer is a disease in which cells grow abnormally and conquer the other tissues in the body. This uncontrolled spreading of cells causes cancer tumors. Cancer is also known as malignant tumor or neoplasms. These tumors can be benign or malignant. To detect and cure the cancer cells, the cancer vaccines are used. These vaccines comprise of antigenic components that strengthen the immune system by increasing adaptive immunity of individual to prevent disease from infections.

Market Dynamics and Trends:
At present, cancer is the second leading cause of illness and death worldwide. A major cause of cancer is gene mutation and in rare cases the disease can also be inherited through genes. The growing occurrence of various types of cancer and the developments of new vaccines are expected to increase the demand for cancer vaccines in the coming years. Increasing administration of prophylactic cancer vaccines and rising investments for the development of new cancer vaccines are expected to fuel the cancer vaccines market growth. Moreover, factors such as emphasis on early diagnosis of cancer, introduction & approval of cancer vaccines and technological developments are expected to boost the demand for cancer vaccines market growth.
However, high cost for development of cancer vaccines, stringent regulatory guidelines and presence of alternative therapists are hampering the market growth. On the other hand, growing number of cancer patients globally and rapid introduction & approval of cancer vaccines are creating opportunities for the market.
Market Segmentations and Scope of the Study:
The global cancer vaccines market is segmented on the basis of technology, type, indication, end user, and geography. On the basis of technology, the market is segregated into dendritic cells cancer vaccines, recombinant cancer vaccine, antigen cancer vaccine and viral vector & DNA cancer vaccines. In terms of type, the market is bifurcated into preventive cancer vaccine and therapeutic cancer vaccine. Based on indication, the market is classified as prostate cancer, cervical cancer, and others. On the basis of end user, the market is divided into adult vaccines and pediatric vaccine. In terms of geography the market is classified as North America, Europe, Asia-Pacific, and Rest of World (RoW).
Geographical Analysis:
North America accounts for a major share of the market due to high adoption of cancer vaccines and presence of a large patient pool and market players.
The market in Asia-Pacific is expected to grow due to increasing healthcare spending and rising consumer awareness.

Competitive Landscape

:
Key players in the market are CSL Limited, Pfizer Inc., Bristol-Myers Squibb, Astrazeneca Plc., Sanofi Pasteur, Aduro BioTech Inc., Sanpower Group, Glaxosmithkline Plc., Merck & Co., Inc., and Astellas Pharma Inc.
KEY MARKET SEGMENTS:
o Global Cancer Vaccines Market – By Technology
• Dendritic Cells (DC) Cancer Vaccines
• Recombinant Cancer Vaccines
• Antigen/Adjuvent Cancer Vaccines
• Viral Vector and DNA Cancer Vaccines
o Global Cancer Vaccines Market –

By Type

• Preventive Vaccine
• Therapeutic Vaccine
o Global Cancer Vaccines Market – By Indication
• Prostate Cancer
• Cervical Cancer
• Others
o Global Cancer Vaccines Market – By End User
• Adults Vaccines
• Pediatric Vaccine
o Global Cancer Vaccines Market – By Geography
• North America
 U.S.
 Canada
 Mexico
• Europe
 UK
 Germany
 France
 Italy
 Rest of Europe
• Asia-Pacific
 China
 India
 Japan
 Australia
 Rest of Asia-Pacific
• RoW
 Argentina
 Turkey
 South Africa
 Brazil
 Remaining Countries"